BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33134164)

  • 1. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC.
    Qian S; Sun S; Zhang L; Tian S; Xu K; Zhang G; Chen M
    Front Oncol; 2020; 10():556018. PubMed ID: 33134164
    [No Abstract]   [Full Text] [Related]  

  • 2. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

  • 3. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Huang H; Zhu L; Huang C; Dong Y; Fan L; Tao L; Peng Z; Xiang R
    Front Oncol; 2021; 11():726655. PubMed ID: 34660292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of
    Yang H; Wang Y; Zhang Z; Li H
    Front Genet; 2020; 11():905. PubMed ID: 32973873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
    Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
    Front Physiol; 2018; 9():399. PubMed ID: 29720944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma.
    Jing X; Xu G; Gong Y; Li J; LingfengWu ; Zhu W; He Y; Li Z; Pan S
    J Clin Lab Anal; 2021 Dec; 35(12):e24031. PubMed ID: 34716619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
    Zhang L; Su Z; Hong F; Wang L
    Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
    Peng Q; Zhou Y; Jin L; Cao C; Gao C; Zhou J; Yang D; Zhu J
    Transl Androl Urol; 2020 Jun; 9(3):1082-1098. PubMed ID: 32676392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.
    Lv D; Wu X; Wang M; Chen W; Yang S; Liu Y; Zeng G; Gu D
    Front Cell Dev Biol; 2021; 9():621618. PubMed ID: 33796525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
    Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
    J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
    [No Abstract]   [Full Text] [Related]  

  • 14. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
    Wang YL; Zhang YY
    Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
    Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
    J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
    Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
    Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
    Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
    J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
    [No Abstract]   [Full Text] [Related]  

  • 18. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
    Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
    Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.